Know How Tresiba Compares to Other Basal Insulins for Type 2 Diabetes

September 2017

Reps will raise questions about whether insulin degludec (Tresiba, etc) is better than other basal insulins (Lantus, etc) for type 2 diabetes.

They're sharing new data that suggest insulin degludec U-100 has a lower risk of symptomatic hypoglycemia than insulin glargine U-100.

But help put this in perspective.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Liver Disease Optimize Meds for Comorbidities in Nonalcoholic Fatty Liver Disease
Neurology & Pain Consider Pros and Cons of Meds for Diabetic Peripheral Neuropathy
Dermatology Tell Patients to Think of New Tattoos as Wounds
Hypertension Watch for Commonly Used Meds and Supplements That May Increase Blood Pressure
Cannabinoids Explain Risks and Benefits of Medical Marijuana
Menopause New Intrarosa Is an Alternative to Vaginal Estrogen for Dyspareunia
Women's Health Point Out Differences in Prenatal Vitamins to Pregnant Women
Multiple Sclerosis Reduce Side Effects of Multiple Sclerosis Meds
Storage & Disposal Don't Break the Cold Chain With Refrigerated and Frozen Meds
Insulin Know How Tresiba Compares to Other Basal Insulins for Type 2 Diabetes
Dosage Forms Be Ready to Answer Questions About Chewable Tabs
Anticoagulants Use a Low-Molecular-Weight Heparin for Most Patients With Cancer-Associated VTE
Compounding Watch for Standardized Compounded Oral Liquid Concentrations

Know How Tresiba Compares to Other Basal Insulins for Type 2 Diabetes

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents